Pharm exam 3 Flashcards

1
Q

What medication classes can cause N/V

A

Anticonvulsants
Antibiotics
Chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the treatment approach to N/V

A

remove offending agent
diet modifications
behavioral interventions
acupuncture
correct dehydration/nutritional deficiencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is N/V treated with pharm

A

often first line used empirically until cause is identified
-serotonin antagonists
May require multiple drugs with distinct MOAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Best options for motion sickness

A

antihistamine
scopolamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Best options for gastroparesis?

A

metoclopramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Best options for N/V postoperative?

A

serotonin antagonist
scopolamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Best option for N/V from pregnancy?

A

pyridoxine
antihistamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Best options for chemotherapy induced N/V

A

serotonin antagonist
phenothiazines
neurokinin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are all the options for N/V treatment

A

antihistamines
scopolamine
metoclopramide
serotonin antagonists
pyridoxine
phenothiazines
neurokinin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the H1 receptor antagonists

A

meclizine
dimenhydrinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

H1 receptor antagonist MOA?

A

non-selectively antagonizes H1 receptors and antagonizes cholinergic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are H1 receptor antagonists most effective for?

A

migraines
motion sickness
vertigo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are H1 receptor antagonists taken

A

oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the adverse effects of H1 receptor antagonists

A

anticholinergic effects:
-dry mouth
-constipation
-blurred vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the serotonin 3 receptor antagonist?

A

odansetron (zofran)
other -setron’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 5-HT3 most effective for?

A

CINV
PONV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are 5-HT3s given and adverse effect?

A

oral or parenteral

headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the phenothiazines?

A

promethazine (phenergan)
Prochlorperazine (compazine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe phenergan

A

nonselective antagonist at histamine H1 receptors

anticholinergic properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe compazine

A

selectively antagonizes Dopamine D2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are phenothiazines most effective for

A

migraine
motion sickness
vertigo
CINV
PONV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How can phenothiazines be administrated and adverse effects?

A

oral
rectal
parenteral

Anticholinergic
EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is a dopamine (3) receptor antagonist and MOA?

A

metoclopramide (reglan)

stimulates upper GI tract motility
Antagonizes central and peripheral dopamine receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are dopamine (3) receptor antagonists most effective for? Route? ADE?

A

gastroparesis

oral/parenteral

EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is an antimuscarinic

A

scopolamine transdermal (transderm Scop)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Antimuscarinic most effective? route? ADE?

A

motion sickness

Transdermal

Somnolence and Xerostomia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What medications can cause diarrhea?

A

antibiotics
laxatives
lithium
metoclopramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are some non pharm treatments for diarrhea?

A

remove causative agent
fluid and electrolyte correction
oral rehydration
BRAT diet
-bananas
-rice
-applesauce
-toast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the antidiarrheal agents

A

loperamide
diphenoxylate
bismuth salicylate (pepto-bismol)
Octreotide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Describe loperamide

A

gut wall opioid receptor
4mg initially, then 2mg after each unformed stool (max 16mg/day)
oral route
available OTC
may cause constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Describe diphenoxylate/atropine (Lomotil)

A

Schedule V
binds opioid receptors
may cause abdominal discomfort, N/V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Describe bismuth subsalicylates

A

oral
may cause stool and tongue discoloration
avoid in pregnancy/lactation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Describe octreotide

A

Typically used for refractory diarrhea
typically used to treat acromegaly
SubQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Describe probiotics

A

variable dosing
well tolerated
prevents diarrhea associated with antibiotic use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the complications of diarrhea

A

hypovolemia
-hyponatremia when combined with increased water ingestion

metabolic acidosis

hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is the most critical part of treating diarrhea

A

volume repletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How should volume be repleted after diarrhea

A

oral route is preferred
solutions containing water, sodium, glucose
commercially prepared oral rehydration
-equimolar concentrations with osmolarity between 200-310

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How should oral hydration be done in mild-mod hypovolemia

A

5mL every 1-2 minutes by spoon or syringe
PLUS
maintenance calories and fluids administered to replace ongoing losses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

When is oral rehydration therapy contraindicated?

A

mental status changes (aspiration)
inadequate absorption (ileus)
severe hypovolemia
persistent vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

How should hypovolemia be replenished IV?

A

20mL/kg rapid infusion of isotonic saline

convert to oral rehydration therapy when patient is stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What medications cause constipation

A

antihistamines
antidiarrheal agents
diuretics
opioids
tricyclic antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

When should constipation be treated?

A

when it reduces patients quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

How to treat constipation non-pharm

A

identify medication related causes
-switch or remove
increase hydration (8-8ounce cups)
increase fiber to 20-30g
increase physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Describe bulking agents

A

increase water content of stool
onset in 3 days
Psyllium (metamucil)
increase stool frequency
ADE: bloating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Describe stimulants

A

stimulate mucosal nerve plexus of colon
may alter fluid/electrolyte transport
Senna (senokot)
Bisacodyl (dulcolax)
onset in 8-12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Describe osmotics

A

lactulose
polyethylene glycol (miraLAX)
nonsabsorbable disaccharide
results in colon retaining fluid
onset 2-3 days
ADE: flatulence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Describe polyethylene glycol

A

an osmotic
minimal ADE
onset 1-3 days
OTC
safe in pregnancy

48
Q

Describe emollients (stool softeners)

A

increase stool moisture content - easier to pass stool
prevention of constipation
Docusate (colace)

49
Q

Describe glycerin

A

intermittent constipation or fecal impaction

suppository

onset in 30-60 minutes

50
Q

Describe lubiprostone

A

Rx
approved for:
-idiopathic chronic constipation
-opioid induced constipation
bowel movement occurs within 24-48 hours of use
expensive
contraindicated in patient with obstruction

51
Q

Describe linaclotide

A

Rx
approved for:
-idiopathic constipation
-IBS C

52
Q

What meds should be used for IBS constipation?

A

laxative
linaclotide
lubiprostone

53
Q

What meds should be used for IBS diarrhea?

A

loperamide
alosetron

54
Q

What meds should be used for bloating (IBS)

A

Rifaximin
probiotics

55
Q

What meds should be used for IBS pain

A

antispasmodics
antidepressants

56
Q

What type of laxative is not recommended for IBS-C

A

stimulants

but can use psyllium and polyethylene glycol

57
Q

What type of population can use lubiprostone for IBS-C

A

adult women

58
Q

What does lubiprostone treat for IBS-D

A

just reduces frequency not pain or other symptoms

59
Q

Who can use alosetron to treat IBS-D

A

women with severe IBS-D unresponsive to other meds

60
Q

What meds can be used for any IBS subtype for bloating

A

Rifaximin for bloating
-nonabsorbable antibiotic

61
Q

What meds can be used for any IBS subtype for pain

A

antispasmodics
-short term relief for abdominal pain
-dicyclomine/hyoscyamine
Antidepressants
-TCA
-SSRI*

62
Q

What is considered mild UC

A

<4 stools/day
no systemic signs of toxicity

63
Q

what is considered moderate UC

A

> 4 stools/day
minimal signs of toxicity

64
Q

What is considered severe UC

A

> 6 stools/day + blood
systemic signs of toxicity

65
Q

What is considered fulminant UC

A

> 10 stools/day with continuous bleeding
blood transfusion may be needed
colonic dilation

66
Q

What is considered mild-mod crohn’s

A

CDAI 150-220
ambulatory
no:
-dehydration
-systemic toxicity
-abdominal tenderness/mass
-obstruction

67
Q

What is considered mod-severe Crohn’s

A

CDAI 220-450
failed treatment for mild-mod
fever
abd tenderness/pain
vomiting
weight loss

68
Q

What is considered fulminant crohn’s disease

A

CDAI >450
persistent symptoms despite OP therapy
High temp
persistent vomiting
obstruction/abscess

69
Q

What are the goals of IBD therapy and types?

A

symptoms reduction
prevent relapse
decrease CRC risk

induction therapy - control acute symptoms
maintenance therapy once acute attack is under control

70
Q

What is the step-up approach to IBD

A

start with 5-ASA, topical corticosteroids

immunomodulators and biologics:
-reserved for maintenance
-failure of therapy
-relapses

71
Q

What is the top-down approach to IBD

A

early therapy with immunomodulators or biologics
transition then to standard conventional agents
may help with mucosal healing and prevent complications to start with aggressive therapy early

72
Q

How to start induction therapy for mild-mod UC if distal location

A

Standard:
-topical mesalamine
-oral sulfasalazine or mesalamine
-topical corticosteroids
-aminosalicylates

Additional options:
-oral corticosteroids
-infliximab

73
Q

How to start induction therapy for UC if severe disease

A

not hospitalized:
-infliximab
-oral aminosalicylate if previously taking

hospitalized:
-IV corticosteroid

74
Q

What is the maintenance therapy for mild-mod UC if distal location

A

standard:
-topical mesalamine
-oral sulfasalazine or aminosalicylate
-topical + oral aminosalicylate

Additional options:
-thiopurines
-infliximab

75
Q

What is the maintenance therapy for UC if severe disease?

A

continue what provided symptom improvement

Corticosteroids: taper to lowest effective dose

76
Q

How should induction therapy be done with mild-mod UC that is located distal to the splenic flexure? maintenance?

A

first line for both:
-aminosalicylates

77
Q

What are not effective for maintenance therapy for mild-mod distal UC?

A

topical corticosteroids
-hydrocortisone
-budesonide

78
Q

What should be done for induction therapy for extensive UC disease that is proximal to the splenic flexure? maintenance?

A

Both:
-oral sulfasalazine OR aminosalicylate

79
Q

What should be used for induction therapy for UC in severe disease that is refractory to aminosalicylates?

A

hospitalized:
-IV corticosteroids for 7-10 days

not hospitalized:
-infliximab

80
Q

What should be used for MAINTENANCE therapy for UC in severe disease that is refractory to aminosalicylates?

A

Switch from IV formulation of corticosteroids and taper to lowest effective dose

If IV cyclosporine, transition to oral

Last line - colectomy

81
Q

Meds for induction therapy of mild-mod crohn’s?

A

oral aminosalicylate

82
Q

Meds for induction therapy of mod-severe Crohn’s?

A

oral corticosteroids

83
Q

Meds for induction therapy of severe-fulminant crohn’s?

A

IV corticosteroids
IV Cyclosporine
consider surgical intervention

84
Q

Crohns mod-severe maintenance treatment

A

corticosteroid taper
infliximab

based off therapy that achieved remission

85
Q

Crohn’s severe-fulminant maintenance therapy

A

corticosteroid taper/transition to oral therapy

86
Q

Crohn’s mild-mod maintenance treatment

A

budesonide

87
Q

What does sulfasalazine target

A

the colon

It is a 5-ASA

88
Q

What forms does mesalamine come in?

A

suppository
enema
enteric-coated
delayed release
extended release

it is a 5-ASA

89
Q

5-ASA (aminosalicylates) are first line for?

A

mild-moderate IBD

90
Q

What may be beneficial to allow drug to target a specific location?

91
Q

How do prodrugs work?

A

have carrier that facilitate specific actions at a particular location
-drug release only at specific spot

92
Q

5-ASA routes?

A

oral
enemas
suppositories

93
Q

When are 5-ASA not used?

A

acute severe cases of IBD

94
Q

What should be done if treatment fails with 5-ASA

A

discontinue and do not transition to another 5-ASA

95
Q

In treating mild to mod UC, how should 5-ASA be used?

A

Use prodrug formulations to allow targeted release in the colon

96
Q

What is a limitation of sulfasalazine (5-ASA)?

A

cannot be used in patients with a sulfa allergy

97
Q

How should corticosteroids be used in treatment of IBD?

A

Used for induction then taper
If needed maintenance, oral prednisone 20-60mg/day
IV hydrocortisone or methylprednisolone

Place in therapy:
-induction for IBD
-symptoms control not achieved with alt. agents
-severe illness

98
Q

What are the immunomodulators used in IBD treatment

A

thiopurines:
-6-mercaptopurine
-azathiprine

methotrexate

calcineurin inhibitors
-cyclosporine
-tacrolimus

99
Q

thiopurines MOA

A

inhibit purine synthesis
apoptosis of T cells

*used for maintenance therapy

100
Q

ADE of thiopurines

A

dose dependent:
-nausea
-hepatitis
-infection risk

long term:
-increased risk of lymphoma; often the benefit outweighs the risk

101
Q

Describe methotrexate in IBD treatment

A

inhibits DNA synthesis, repair, replication
-reduced folates

IM or SC weekly

increased risk of infection/malignancy and myelosuppression

NOT EFFECTIVE in UC; only crohn’s

102
Q

Calcineurin inhibitor MOA

A

suppress synthesis of pro-inflammatory cytokines

103
Q

What are the anti-TNF alpha therapies and MOA?

A

infliximab (remicade)
adalimumab (humira)

elevated TNF alpha levels found in patients with Crohn’s and UC

104
Q

Describe infliximab

A

Induction is IV weeks 0, 2, 6
maintenance is IV every 8 weeks
administer over 2 hours
premedicate with
-antihistamine
-acetaminophen
-corticosteroids
contraindicated with active infection
ADE: increased infection/malignancy risk

105
Q

Describe adalimumab

A

SubQ injection on days 1, 15, and 29
-doses go 160, 80, then 40
after day 29, continue 40mg every other week
ADE: increased risk of malignancy/infection

106
Q

Describe certolizumab

A

weeks 0,2,4 then every 4 weeks maintenance
ADE: increased infection and malignancy risk

107
Q

Key points of anti-TNF alpha therapies

A

infection risk with all agents - risk vs benefit

prior to starting, screen:
-TB
-HBV
-HCV

Pt ed: avoid live vaccines during therapy

108
Q

What anti TNF alpha therapies can be used for crohn’s?

A

all agents

109
Q

What anti TNF alpha therapy can be used for UC

A

infliximab

110
Q

What is an Anti-a4 integrin antibody

A

Natalizumab (Tysabri)

111
Q

What is natalizumab useful for?

A

inducing remission and for maintenance in moderate to severe crohn’s and UC

112
Q

natalizumab ADE and CI?

A

increased infection
increased malignancy risk

CI:
-use with other immunosuppressants or anti TNF alpha agents
-hepatic disease

113
Q

What is rotavirus

A

virus that spreads quickly among infants and children
-watery diarrhea
-dehydration
-hospitalization

114
Q

What are the rotavirus vaccines available

A

RotaTeq (RV5) 2,4,6 months
Rotarix (RV1) 2,4 months

Given by putting drops in infant’s mouth

115
Q

Is it ok to give rotavirus vaccine when infant is ill?

A

mild illness - acceptable
mod-severely ill - wait until recovery